US2014178500A1PendingUtilityA1
Methods of treating outer eye disorders using high orp acid water and compositions thereof
Est. expiryJun 17, 2029(~2.9 yrs left)· nominal 20-yr term from priority
A61P 27/02A61P 27/12A61K 33/20
43
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a method of treating an outer eye disorder selected from a cataract, neovascularization, keratitis, epithelium deficiency, or chronic opacity, by administering to the eye a composition comprising acidic electrolytic water. The present invention also relates to a stable acidic electrolyzed oxidizing water characterized by low conductivity, the presence of dissolved chlorine gas (Cl 2 ), hypochlorous acid (HOCl) and chloride ions (Cl − ), and by the presence of negligible quantities of hypochlorite ion (OCl − ).
Claims
exact text as granted — not AI-modified1 ) A method of treating a condition selected from cataract, ocular keratitis, corneal neovascularization, epithelium deficiency, and chronic opacity in a lens in an animal patient in need thereof, comprising topically administering to an eye of said patient a composition comprising a therapeutically effective amount of a high ORP acidic water.
2 ) The method of claim 1 , wherein said high ORP acidic water has an ORP of greater than 1100 mV, and a pH of from 0.5 to 5.0.
3 ) The method of claim 1 , wherein said high ORP acidic water has a NMR half line width using 17 O of from 42 to 60 Hz, and a pH of about 0.5 to about 5.0.
4 ) The method of claim 1 , wherein said administering step comprises dropping said composition directly into said eye.
5 ) The method of claim 1 , wherein said administering step comprises applying said composition to said eye with a piece of gauze.
6 ) The method of claim 1 , wherein said administering step comprises applying said composition to said eye 1 to 20 times per day, for at least 14 days.
7 ) An electrolytic acid water comprising free chlorine, wherein:
a) from 95% to 99.9% of said free chlorine is present in the form of hypochlorous acid; b) said water has a pH of from 1.0 to 4.0; and c) said water has an ORP of greater than 1100 mV.
8 ) An electrolytic acid water comprising free chlorine, wherein:
a) from 90% to 99.9% of said free chlorine is present in the form of hypochlorous acid; b) said water has a pH of from 1.0 to 4.0; and c) said water has an ORP of greater than 1100 mV.
9 ) The electrolytic acid water of claim 7 , wherein the relative amount of HOCl and Cl 2 is from 99.9% HOCl and 0.1% Cl 2 to 95% HOCl to 5% Cl 2 .
10 ) The electrolytic acid water of claim 7 , wherein the relative amount of HOCl and Cl 2 is from 99.5% HOCl and 0.5% Cl 2 to 98.5% HOCl to 1.5% Cl 2 .
11 ) The electrolytic acid water of claim 7 , having a NMR half line width using 17 O of from 42 to 60 Hz.
12 ) The electrolytic acid water of claim 7 , wherein said water has a conductivity of from 1200 to 1400 uS/cm.
13 ) The electrolytic acid water of claim 7 , wherein said water maintains 90% of said free chlorine after a storage period of 3 months at room temperature.
14 ) The electrolytic acid water of claim 7 , wherein said water maintains 80% of said free chlorine after a storage period of 3 months at room temperature.Join the waitlist — get patent alerts
Track US2014178500A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.